Of the three nutrient-sensing pathways, the pathological roles of mTOR and the therapeutic potential of rapamycin, an inhibitor of mTOR, in diabetic nephropathy are increasingly being examined in experimental animal models (Table 1). The gene discussed is MTOR; the disease is diabetic kidney disease.